Among the highlights of the March 2018 quarterly performance report for the ERI Scientific Beta indices:
- ERI Scientific Beta offers smart factor indices providing exposure to the six well-known rewarded factors (Mid Cap, Value, High Momentum, Low Volatility, High Profitability and Low Investment) that are also well-diversified in order to reduce the specific risks. This quarter, ending March 31, 2018, the best performing index in the Developed universe among those smart factor indices is the SciBeta Developed Narrow High Factor Intensity High Momentum Diversified Multi-Strategy index with a relative return of 2.03% compared to the broad cap-weighted index, while the SciBeta Developed Narrow High Factor Intensity Low Volatility Diversified Multi-Strategy index posts the lowest relative return (-0.25%).
- Based on its single smart factor indices, ERI Scientific Beta also offers multi smart factor indices. This quarter, the SciBeta Developed Multi-Beta Multi-Strategy 4-Factor EW index, the SciBeta Developed High Factor Intensity Multi-Beta Multi-Strategy 6-Factor EW index and the SciBeta Developed High Factor Intensity Multi-Beta Multi-Strategy 6-Factor EW Market Beta Adjusted (Leverage) index post positive relative returns of 0.80%, 0.25% and 0.10% respectively compared to cap-weighted indices.
- The Scientific Beta Multi-Beta Multi-Strategy Four-Factor EW indices, which were the first multi-factor indices to be offered by ERI Scientific Beta, show an average live annualised outperformance across all Scientific Beta Developed regions of 2.11% over their four-year live track record and an improvement in the Sharpe Ratio of 46.16% compared to their cap-weighted benchmark1.
1The average live outperformance and improvement in Sharpe Ratio across all Scientific Beta developed regions of Scientific Beta Multi-Beta Multi-Strategy Equal-Weight indices is 2.11% for the outperformance and 46.16% for the improvement in Sharpe Ratio. This live analysis is based on daily total returns in the period from December 20, 2013 (live date) to December 31, 2017 for all diversified multi-strategy indices that have more than 3 years of track record for all available developed world regions - USA, Eurozone, UK, Developed Europe, Developed Europe ex UK, Japan, Developed Asia Pacific ex Japan, Developed ex UK, Developed ex USA and Developed. The benchmark used is a cap-weighted portfolio of all stocks in the respective Scientific Beta universes.
As part of its policy of transferring know-how to the industry, EDHEC-Risk Institute has set up ERI Scientific Beta. ERI Scientific Beta is an original initiative which aims to favour the adoption of the latest advances in smart beta design and implementation by the whole investment industry. Its academic origin provides the foundation for its strategy: offer, in the best economic conditions possible, the smart beta solutions that are most proven scientifically with full transparency of both the methods and the associated risks.
ERI Scientific Beta, 1 George Street, #15-02, Singapore 049145. For further information, please contact: Carolyn Essid, Tel.: +33 493 187 824, E-mail: [email protected], Web: www.scientificbeta.com.
Find out more about the research conducted by EDHEC-Risk Institute on smart beta and the Scientific Beta indices by following us on Twitter (https://twitter.com/ScientificBeta), LinkedIn (https://www.linkedin.com/company/scientific-beta) and YouTube (https://www.youtube.com/channel/UCRL91F-LvhLPc9M9OD7LQgA).
Attachment


Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
World game at war: why some European nations have threatened a World Cup boycott
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook 



